Financial Disclosure Statement:
Financial Support: Supported by National Institutes of Health,
National Cancer Institute (Grant No. U10 CA180899 to Children’s Oncology
Group Statistics and Data Center), National Clinical Trials Network
Operations Center (Grant U10 CA180886), and St Baldrick’s Foundation.
Conflicts of interest : Keri A. Streby is a consultant for
Innervate Radiopharmaceuticals LLC and YmAbs Therapeutics Inc. and Kate
Matthay is a consultant for Innervate Radiopharmaceuticals LLC.